CRISPR Therapeutics

ISIN CH0334081137

WKN A2AT0Z

Market cap (in EUR)

2,767.62 m

Country

Switzerland

Sector

Healthcare

Dividend yield

0.00%

Overview

Description

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

Show more Show less

Healthcare Biopharmaceuticals Other Biopharmaceuticals Switzerland

Financials

Key metrics

Market capitalisation, EUR	2,767.62 m
EPS, EUR	-4.21
P/B ratio	1.71
P/E ratio	-
Dividend yield	0.00%

Income statement (2024)

Revenue, EUR	34.50 m
Net income, EUR	-338.59 m
Profit margin	-981.54%

What ETF is CRISPR Therapeutics in?

There are 31 ETFs which contain CRISPR Therapeutics. All of these ETFs are listed in the table below. The ETF with the largest weighting of CRISPR Therapeutics is the ARK Genomic Revolution UCITS ETF USD Accumulating.

Show entries

Search:

ETF	Gewichtung	Anlagefokus	Fondsgröße Mio. EUR
ARK Genomic Revolution UCITS ETF USD Accumulating	7.64%	Equity World Health Care Innovation	8
ARK Innovation UCITS ETF USD Accumulating	4.93%	Equity World Innovation	84
Global X Genomics & Biotechnology UCITS ETF	4.46%	Equity World Health Care Biotech	7
L&G Healthcare Breakthrough UCITS ETF USD Acc	1.41%	Equity World Health Care Innovation	54
VanEck Genomics and Healthcare Innovators UCITS ETF A	1.29%	Equity World Health Care Social/Environmental Innovation	4
WisdomTree BioRevolution UCITS ETF USD Acc	1.21%	Equity World Health Care Social/Environmental Biotech	3
Xtrackers MSCI Genomic Healthcare Innovation UCITS ETF 1C	0.91%	Equity World Health Care Social/Environmental Innovation	3
Xtrackers World Small Cap Green Transition Innovators UCITS ETF 1C	0.51%	Equity World Small Cap Innovation	4
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)	0.36%	Equity United States Health Care Biotech	21
iShares Nasdaq US Biotechnology UCITS ETF	0.36%	Equity United States Health Care Biotech	341

Showing 1 to 10 of 31 entries

1 2 3 4

justETF Academy Seminarübersicht

12.05.25 Online-Seminar

ETFs für Anfängerinnen und Anfänger

Jetzt kostenlos anmelden

Interessante Artikel Artikelübersicht

— Die verwendeten Daten werden bereitgestellt von Trackinsight, etfinfo, Xignite Inc., gettex, FactSet und justETF GmbH.

Kurse sind entweder Realtime- (gettex) oder 15 Minuten zeitverzögerte Börsennotierungen oder NAVs (täglich vom Fondsanbieter veröffentlicht). Die Wertentwicklungsangaben für ETFs beinhalten standardmäßig Ausschüttungen (falls vorhanden). Es wird keine Gewähr für die Vollständigkeit, Genauigkeit und Richtigkeit der dargestellten Informationen übernommen.